Sort
23,748 grants matching “melanoma”
Sequencing Chr. 6 in Melanoma Patients
$202,500Jeremy S Edwards · University Of New Mexico · R21 · FY2008 · CA
EphB4 as Novel Target for Breast Cancer Imaging
$202,500Peter S Conti · University Of Southern California · R21 · FY2012 · EB
Development of ESiPSC approach for non-germline GEM modeling
$202,437Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Structure-based selection of tumor-antigens for T-cell based immunotherapy
$202,434Lydia E. Kavraki · Rice University · R21 · FY2017 · CA
IGF1R-targeted oncolytic herpes simplex viral therapy for Glioblastoma
$202,429Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R21 · FY2022 · NS
IGF1R-targeted oncolytic herpes simplex viral therapy for Glioblastoma
$202,429Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R21 · FY2023 · NS
Regulation of tumor released exosomes and glutamatergic signaling
$202,275Suzie Chen · Rutgers, The State Univ Of N.J. · R21 · FY2015 · CA
N-cadherin and Metastatic Dissemination
$202,275Glenn Lawrence Radice · Thomas Jefferson University · R21 · FY2015 · CA
Role of Osteoactivin in Invasion by Oral Cancers
$202,275Oneida A Arosarena · Temple Univ Of The Commonwealth · R21 · FY2013 · CA
Molecular Lymphosonography for Sentinel Lymph Node Characterization
$202,275Andrej Lyshchik · Thomas Jefferson University · R21 · FY2014 · CA
Molecular mechanisms controlling cell proliferation during tissue turnover and ca
$202,275Nestor Oviedo · University Of California, Merced · R21 · FY2015 · CA
Therapeutic potential of TCR-like recombinant antibodies
$202,248Yoram Reiter · Technion-Israel Institute Of Technology · R01 · FY2007 · CA
Therapeutic potential of TCR-like recombinant antibodies
$202,248Yoram Reiter · Technion-Israel Institute Of Technology · R01 · FY2008 · CA
Development of a nanosecond pulsed electric field system to treat skin cancer
$202,211Richard Lee Nuccitelli · Bioelectromed Corporation · R43 · FY2008 · CA
Understanding the role of serine metabolism in cancer
$202,191Matthew G. Vander Heiden · Massachusetts Institute Of Technology · R21 · FY2015 · CA
IFN-lambda signal transduction
$202,045Ana M Gamero · Basic Sciences · Z01 · FY2007 · CA
Developing a strategy to identify & validate pharmacodynamic kinase inhibitor biomarkers
$202,026Charles J. Bieberich · University Of Maryland Baltimore County · R21 · FY2017 · CA
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
$202,022Bin Zhang · Northwestern University At Chicago · R01 · FY2025 · CA
Clinical Cytophone platform for detection of circulating melanoma cells.
$201,984James Suen · Cytoastra, Llc · R41 · FY2020 · CA
Identification of small molecule inhibitors of USP15
$201,957Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Mechanisms of concomitant tumor immunity and autoimmunity
$201,886Mary J Turk · Dartmouth College · R01 · FY2013 · CA
Adipokine Signaling in Melanoma: Unmasking the Obesity Paradox.
$201,875Thomas P Loughran · University Of Virginia · P30 · FY2024 · CA
Overcoming immune checkpoint inhibition with therapeutic plasma exchange and radiotherapy in melanoma
$201,871Sean S Park · Mayo Clinic Rochester · R21 · FY2021 · CA
Project 1: Genotoxic & Cell Signaling Pathways of As in Mammalian Cells
$201,858Tom K Hei · Columbia University Health Sciences · P42 · FY2007 · ES
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$201,845Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR